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Glutamate, the principal excitatory neurotransmitter in the spinal cord, acts primarily through AMPA receptors. Although all four AMPA
subunits are expressed by spinal neurons, we know little about their distribution at glutamatergic synapses. We used an antigen-
unmasking technique to reveal the synaptic distribution of glutamate receptor (GluR) 1– 4 subunits with confocal microscopy. After
pepsin treatment, punctate staining was seen with antibodies against each subunit: GluR2-immunoreactive puncta were distributed
throughout the gray matter, whereas GluR1-immunoreactive puncta were restricted to the dorsal horn and were most numerous in
laminas I–II. Punctate staining for GluR3 and GluR4 was found in all laminas but was weak in superficial dorsal horn. Colocalization
studies showed that GluR2 was present at virtually all (98%) puncta that were GluR1, GluR3, or GluR4 immunoreactive and that most
(90%) immunoreactive puncta in laminas IV, V, and IX showed GluR2, GluR3, and GluR4 immunoreactivity.
Evidence that these puncta represented synaptic receptors was obtained with electron microscopy and by examining the association of
GluR2- and GluR1-immunoreactive puncta with glutamatergic boutons (identified with vesicular glutamate transporters or markers for
unmyelinated afferents). The great majority (96%) of these boutons were associated with GluR2-immunoreactive puncta. Our findings
suggest that GluR2 is almost universally present at AMPA-containing synapses, whereas GluR1 is preferentially associated with primary
afferent terminals.
We also found a substantial, rapid increase in staining for synaptic GluR1 subunits phosphorylated on the S845 residue in the
ipsilateral dorsal horn after peripheral noxious stimulation. This finding demonstrates plastic changes, presumably contributing to
central sensitization, at the synaptic level.
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Introduction
Glutamate is the main excitatory neurotransmitter in the spinal
cord and is used by primary afferents, excitatory interneurons,
projection neurons, and some descending axons (Broman, 1994).
Glutamate acts on ionotropic glutamate receptors (iGluRs) and
metabotropic glutamate receptors, which are widely expressed by
spinal neurons (Coggeshall and Carlton, 1997). iGluRs can be
divided into three classes on the basis of their preference for
AMPA, kainate, or NMDA. AMPA receptors mediate fast EPSPs
in spinal neurons (Yoshimura and Jessell, 1990; Yoshimura and
Nishi, 1992) and are responsible for transmission of nociceptive
signals perceived as acute pain (Dickenson et al., 1997). AMPA
receptors have also been implicated in excitotoxicity and degen-
eration of motoneurons in amyotrophic lateral sclerosis (van
Damme et al., 2002).
mRNAs for all four subunits of the AMPA receptor
(GluR1– 4) have been identified in the spinal cord (Furuyama et
al., 1993; Henley et al., 1993; To¨lle et al., 1993, 1995; Jakowec et
al., 1995b; Shibata et al., 1999). Although conventional immuno-
cytochemical studies have been performed to detect AMPA sub-
units (Tachibana et al., 1994; Jakowec et al., 1995a; Popratiloff et
al., 1996, 1998; Morrison et al., 1998; Spike et al., 1998), it is
unlikely that these revealed receptors at glutamatergic synapses,
because these are thought to be inaccessible due to extensive
cross-linking of the protein meshwork of the synaptic cleft and
postsynaptic density that results from aldehyde fixation (Baude et al.,
1995; Ottersen and Landsend, 1997; Fritschy et al., 1998; Watanabe
et al., 1998). Postembedding immunogold-labeling has been used to
investigate synaptic AMPA receptors in the spinal cord (Popratiloff
et al., 1996, 1998; Morrison et al., 1998; Ragnarson et al., 2003);
however, despite this, the pattern of AMPA subunit expression
at individual synapses remains largely elusive.
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There are major differences between AMPA subunits in their
physiology, pharmacology, and involvement in synaptic plastic-
ity (Dingledine et al., 1999). For example, the subunits differ in
their response to phosphorylation (Bredt and Nicoll, 2003), a
process that is thought to contribute to central sensitization of
dorsal horn neurons in chronic pain states (Sandku¨hler, 2000;
Fang et al., 2003; Ji et al., 2003). In addition, absence of the GluR2
subunit results in Ca 2 permeability, which has been implicated
in certain pathological conditions (Sorkin et al., 1999, 2001; Van-
denberghe et al., 2001). Knowledge of the subunit composition at
synapses in specific neuronal circuits is therefore of fundamental
importance for our understanding of synaptic function and
plasticity.
In this study, we examined synaptic AMPA subunits with con-
focal and electron microscopy by adopting a proteolytic antigen-
unmasking method that allows antibodies to gain access to syn-
aptic receptors (Watanabe et al., 1998). We provide the first
demonstration of the laminar distribution of all four AMPA sub-
units at synapses in the spinal cord, and for GluR1 and GluR2
subunits, we investigated their relationship to different types of
glutamatergic axon. We also show that this method can be used in
functional studies, because we were able to demonstrate phos-
phorylation of GluR1 at synapses in the superficial dorsal horn in
response to noxious stimulation.
Materials and Methods
GluR antibodies. A rabbit antibody against the C-terminal amino acid
residues 830 – 862 of mouse GluR3 (GenBank accession number
AB022342) and a guinea pig antibody against residues 245–273 of mouse
GluR4 (GenBank accession number AB022913) were generated as de-
scribed previously (Fukaya and Watanabe, 2000). Using the pGEX4T-2
plasmid vector (Amersham Biosciences, Bucks, UK), proteins were ex-
pressed as a glutathione S-transferase (GST) fusion protein and purified
using glutathione-Sepharose 4B (Amersham Biosciences). After throm-
bin digestion, antigen polypeptides (R3C and R4N) were separated from
GST by reverse-phase HPLC. Purified polypeptides were injected into
female rabbits and guinea pigs at intervals of 2 weeks. Antibodies for
GluR3 (GluR3C) and GluR4 (GluR4N) were affinity-purified using GST
fusion protein-coupled cyanogen bromide-activated Sepharose 4B (Am-
ersham Biosciences).
To test the specificity of these antibodies, spinal cords of adult
C57BL/6 mice were homogenized in 8 –10 volumes of ice-cold buffer
containing 0.32 M sucrose, 1 mM EDTA, 1 mM EGTA, 10 mM Tris-HCl,
pH 7.2, and 0.4 mM phenylmethylsulfonyl fluoride (homogenization
buffer) using a Potter homogenizer with 15 strokes at 800 rpm. To obtain
a postsynaptic density (PSD) fraction, the homogenate was centrifuged
at 1000 g for 10 min to remove nuclei and large debris. The supernatant
was centrifuged at 10,000 g for 20 min to obtain a crude synaptosomal
fraction and subsequently lysed hypo-osmotically and centrifuged at
25,000  g for 30 min to pellet a synaptosomal fraction. The pellet was
suspended with homogenization buffer containing 0.5% Triton X-100
for 15 min and centrifuged at 111,000 g for 1 hr to pellet a PSD fraction.
The protein concentration was determined by Lowry’s method. After
SDS-PAGE, fractionated samples in the gel were electroblotted onto ni-
trocellulose membranes (BioTraceNT; Pall Gelman Laboratory, Ann Ar-
bor, MI). Membranes were incubated with 5% skimmed milk in Tris-
buffered saline (TBS) containing 0.1% Tween 20 (TBST), pH 7.5, for 1
hr, followed by incubation with primary antibodies (1 g/ml) in TBST
for 2 hr. Immunoreaction was visualized with the ECL chemilumines-
cence detection system (Amersham Biosciences). For preabsorption ex-
periments, peptides (0.2 g/ml) were added to the primary antibodies.
To check the cross-immunoreactivity of GluR3C antibody to the GluR2
subunit, a dot blot assay was performed using C-terminal peptides for
GluR2 and GluR3 subunits (amino acid residues 826 – 858 of GluR2,
R2C; 830 – 862 of GluR3, R3C). After the peptides were dotted onto
nitrocellulose membranes, immunoreaction was performed as above.
The affinity-purified rabbit antibodies against GluR1 and GluR2 used
in this study (Chemicon International, Harlow, UK) show no cross-
reactivity with other GluR subunits (specification of manufacturer). The
mouse monoclonal anti-GluR2 (Chemicon; clone 6C4) has been exten-
sively characterized and shown not to detect any other AMPA or kainate
subunits (Vissavajjhala et al., 1996).
Animals for immunocytochemistry. Experiments were approved by the
University of Glasgow Ethical Review Process Applications Panel and
performed in accordance with the UK Animals (Scientific Procedures)
Act 1986. Twelve adult male Wistar rats (220 –390 gm; Harlan, Lough-
borough, UK) were deeply anesthetized with pentobarbitone (300 mg,
i.p.) and perfused transcardially with fixative containing 4% freshly de-
polymerized formaldehyde (10 rats) or 4% formaldehyde/0.1% glutaral-
dehyde (two rats). Three additional rats (280 –330 gm) were used to
investigate phosphorylation of the GluR1 subunit in response to noxious
stimulation. These were anesthetized with ketamine and xylazine (73.3
and 7.3 mg/kg, i.p., respectively) and received an injection of 250 g of
capsaicin (Sigma, Poole, UK; dissolved in 25l of 7% Tween 80 in saline)
into the plantar surface of the left hindpaw. They were maintained under
general anesthesia and perfused with 4% formaldehyde under terminal
pentobarbitone anesthesia 10 min after the capsaicin injection.
Lumbar spinal cord segments from all animals were removed, stored
in fixative for 8 –24 hr, and cut into transverse 60m Vibratome sections,
which were immersed in 50% ethanol for 30 min to enhance antibody
penetration.
Immunofluorescent detection of GluR1– 4. To expose AMPA receptor
subunits at synaptic sites, sections were processed according to an
antigen-unmasking method involving pepsin digestion (Watanabe et al.,
1998). In some experiments, glutamatergic axons were identified with
antibodies against the vesicular glutamate transporters VGLUT1 and
VGLUT2, which are primarily associated with myelinated primary affer-
ents and excitatory interneurons, respectively (Todd et al., 2003). Unmy-
elinated (C) primary afferents generally do not have detectable levels of
these transporters (Todd et al., 2003), and we therefore identified pepti-
dergic and nonpeptidergic C afferents with an antibody against calcito-
nin gene-related peptide (CGRP) and binding of Bandeiraea simplicifolia
isolectin B4 (IB4), respectively. After pepsin treatment, staining for these
axonal markers disappeared near the surfaces of the Vibratome section,
where punctate staining for the GluRs was optimal. Detection of these
compounds was therefore performed before pepsin treatment with the
tyramide signal amplification (TSA) method, which resulted in deposi-
tion of covalently bound fluorophore that was resistant to proteolysis.
Pepsin treatment was performed by incubating sections at 37°C for 30
min in PBS followed by 10 min in 0.2 M HCl containing 1 mg/ml pepsin
(Dako, Glostrup, Denmark). For sections processed for confocal micros-
copy, the PBS contained 0.3% Triton X100.
To investigate the relationship between GluR1, GluR2, and various
types of glutamatergic bouton, sections were incubated for 72 hr at 4°C in
one of the following: (1) guinea pig anti-VGLUT1 (Chemicon; 1:200,000
or 1:500,000), (2) guinea pig anti-VGLUT2 (Chemicon; 1:50,000), (3) a
mixture of both guinea pig VGLUT antibodies (at the corresponding
concentrations), (4) guinea pig anti-CGRP (Bachem, Merseyside, UK;
1:100,000), or (5) biotinylated IB4 (Sigma; 2 g/ml). They were then
incubated for 2 hr at room temperature in biotinylated donkey anti-
guinea pig IgG (Jackson ImmunoResearch, West Grove, PA; 1:500)
(except for those treated with IB4) and processed with a TSA kit (tetra-
methylrhodamine; PerkinElmer Life Sciences, Boston, MA) according to
the instructions of the manufacturer. Sections were rinsed, pepsin
treated, and incubated for 24 hr at 4°C in a mixture of rabbit anti-GluR1
(1:500) and mouse anti-GluR2 (3.9 g/ml), followed by 2–24 hr in spe-
cies-specific donkey secondary antibodies: anti-mouse IgG conjugated to
Alexa 488 (Molecular Probes, Eugene, OR; 1:500) and anti-rabbit IgG
conjugated to Cyanine 5.18 (Cy5; Jackson ImmunoResearch; 1:100).
They were mounted with anti-fade medium and stored at 20°C. Sec-
tions from three rats were processed with each of these antibody
combinations.
We performed triple-immunofluorescence labeling to examine the
relationship between GluR2, GluR3, and GluR4. Sections from three rats
were pepsin treated and incubated for 72 hr at 4°C in a mixture of mouse
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anti-GluR2 (3.9 g/ml), rabbit anti-GluR3 (GluR3C) (0.41 g/ml), and
guinea pig anti-GluR4 (GluR4N) (0.76 g/ml), followed by species-
specific donkey secondary antibodies (anti-mouse and guinea pig IgG
conjugated to Cy5 or Rhodamine Red, 1:100, Jackson ImmunoResearch;
anti-rabbit IgG conjugated to Alexa 488, 1:500, Molecular Probes).
Preabsorption controls for the GluR3 and GluR4 antibodies were per-
formed by adding R4N peptide to the GluR4 antibody and R2C or R3C
peptide to the GluR3 antibody (10 g/ml peptide added to 50 g/ml
antibody in each case) and then diluting the antibody to the concentra-
tions above. To compare staining obtained with rabbit and mouse GluR2
antibodies, some sections were treated with pepsin and incubated in a
mixture of these two primary antibodies, followed by appropriate fluo-
rescent secondary antibodies.
To assess the effect of pepsin treatment, nonpepsin-treated sections
were incubated in rabbit anti-GluR1 (1:500), mouse anti-GluR2 (3.9
g/ml), rabbit anti-GluR3 (0.41 g/ml), or guinea pig anti-GluR4 (0.76
g/ml), followed by fluorescent secondary antibodies.
Confocal microscopy and analysis of GluR1– 4. Sections reacted with
antibodies against GluR2, GluR3, and GluR4 were analyzed to determine
the extent of colocalization of these subunits in immunoreactive puncta.
One section from each of three animals was scanned through a 60
oil-immersion lens with a Bio-Rad (Hemel Hempstead, UK) Radiance
2100 confocal laser-scanning microscope. Z-series were scanned at 0.3
m z-separation through the top 10 –15 m of the section, and five
regions were analyzed in each case: laminas I/II, III, IV, V, and IX. Con-
focal image stacks were analyzed with MetaMorph software (Universal
Imaging, Downington, PA). The three-color channels were merged and
combined into a monochrome image, so that the subunit combination in
each punctum could not be determined. One hundred immunoreactive
puncta were selected from each region in each animal. To avoid bias, a
100-square grid was placed on the image, and the punctum closest to
bottom right corner of each grid square was selected. Selected puncta
were then examined in the three-color image stack to determine which
types of subunit immunoreactivity they expressed.
From each of three rats, a single section reacted with anti-GluR1 and
anti-GluR2, together with anti-VGLUT1, anti-VGLUT2, anti-CGRP, or
biotinylated IB4, was analyzed. These sections were scanned through a
60 oil-immersion lens as described above. VGLUT1- and VGLUT2-
labeled boutons were analyzed in laminas I, II, III, IV, V, and IX. Most
VGLUT1 terminals in the inner half of lamina II (IIi) belong to myelin-
ated primary afferents, whereas those in outer lamina II (IIo) are not of
primary afferent origin (Todd et al., 2003). We therefore analyzed lami-
nas IIi and IIo separately for both VGLUTs. CGRP- and IB4-labeled
axons were analyzed in the regions in which they were most numerous:
laminas I/IIo (CGRP) and lamina II (IB4). Confocal image stacks were
viewed with MetaMorph such that only the axonal marker was visible,
and 100 labeled axons were randomly selected from each region in each
animal. The other two confocal channels were then viewed, and the
number of GluR1- and/or GluR2-immunoreactive puncta in contact
with each bouton was determined.
VGLUT1 and VGLUT2 are thought to label the great majority of glu-
tamatergic terminals in the spinal cord, apart from those belonging to C
afferents. To investigate the proportion of GluR2 puncta that was in
contact with glutamatergic terminals, and thus likely to represent synap-
tic receptors, we therefore analyzed sections reacted with antibodies
against both transporters and GluR2. One section from each of three
animals was scanned through a 60 oil-immersion lens, and three re-
gions were analyzed in each case: laminas I/II, III/IV, and IX. Image
stacks were initially viewed such that only GluR2 staining was visible, and
100 immunoreactive puncta were selected from each region in each an-
imal using a grid to avoid bias. The VGLUT staining was then examined,
and the proportion of selected puncta in contact with a VGLUT-
immunoreactive bouton was determined.
Electron microscopy. Although AMPA subunits have been found in
primary afferent terminals in the spinal cord (Lu et al., 2002), we did not
see GluR immunostaining that appeared to be located inside primary
afferent boutons after pepsin treatment (see Results). However, we could
not rule out the possibility that some of the punctate labeling apposed to
primary afferent terminals corresponded to receptors in the presynaptic
membrane. We therefore performed electron microscopy to confirm that
the punctate labeling seen with GluR1 and GluR2 antibodies represented
postsynaptic receptors. Sections from the two rats fixed with formaldehyde/
glutaraldehyde were treated with 1% sodium borohydride for 30 min fol-
lowed by pepsin and incubated in rabbit anti-GluR1 (1:2,000) or rabbit
anti-GluR2 (1:500) for 72 hr and in biotinylated donkey anti-rabbit IgG
(Jackson ImmunoResearch; 1:500) followed by Extravidin-peroxidase con-
jugate (Sigma; 1:1000), each for 24 hr. Peroxidase was revealed with 3,3-
diaminobenzidine, and the sections were osmicated, dehydrated in acetone,
and flat-embedded in Durcupan. Ultrathin sections were cut onto Formvar-
coated single-slot grids, stained with lead citrate, and viewed with a Philips
CM100 electron microscope. For comparison, nonpepsin-treated Vi-
bratome sections were processed in parallel.
For the pepsin-treated material, one ultrathin section from each ani-
mal reacted with GluR1 and one reacted with GluR2 were examined. The
region corresponding to laminas I–III was systematically scanned until
50 immunoreactive synapses had been identified on each section, and the
relationship of reaction product to synaptic membranes was noted in
each case. We also noted any immunoreactive vesicle-containing pro-
files. Ultrathin sections from tissue reacted with GluR1 or GluR2 without
pepsin treatment were then viewed (one from each rat for each anti-
body), and an area equivalent to that scanned in the pepsin-treated sec-
tions was examined.
Detection of phosphorylated GluR1 subunits. To determine whether
immunocytochemically detectable changes involving synaptic AMPA re-
ceptors occurred after noxious stimulation, immunolabeling was per-
formed to reveal GluR1 subunits phosphorylated at the Serine 845 site
(GluR1-pS845) (Roche et al., 1996) on sections from three rats that re-
ceived injections of capsaicin into the left hindpaw 10 min before perfu-
sion. Pepsin-treated L4 sections were incubated in a mixture of rabbit
anti-GluR1-pS845 (Covance, Berkeley, CA; 0.5 g/ml) and mouse anti-
GluR2 (3.9 g/ml) for 48 hr, followed by donkey secondary antibodies
(anti-mouse-Alexa 488, 1:500, Molecular Probes; biotinylated anti-
rabbit, 1:500, Jackson ImmunoResearch) for 2 hr. GluR1-pS845 was re-
vealed with the TSA kit. The antibody against GluR2 was used to dem-
onstrate that punctate staining seen with the GluR1-pS845 antibody
corresponded to AMPA-containing synapses, because GluR2 was found
in virtually all puncta that contained GluR1 (see Results).
One section from each rat was scanned through a 60 oil-immersion
lens with the confocal microscope. From these sections, three adjacent
overlapping fields (each 155  155 m) covering the medial half of
laminas I and II of each dorsal horn were scanned sequentially at 1 m
z-separation to reveal GluR1-pS845 and GluR2. The medial half of the
superficial dorsal horn was analyzed because nociceptive primary affer-
ents from the hindpaw terminate in this area. For each dorsal horn, the
three image stacks were stitched together with Adobe Photoshop 7.0
(Adobe Systems, San Jose, CA) to produce a single optical section that
covered the medial half of the dorsal horn, and the area corresponding to
laminas I and II was outlined for subsequent analysis. The red channel
(corresponding to GluR1-pS845) was switched off while this was per-
formed to avoid bias in the selection of the optical section or the area that
was to be analyzed. GluR1-pS845 immunoreactivity was analyzed in each
of the optical sections by setting a threshold for pixel luminance value
that excluded most of the “basal” immunostaining seen in the contralat-
eral dorsal horn. Puncta in each dorsal horn that had at least one pixel
exceeding this threshold value were identified and counted, and the pres-
ence or absence of GluR2 immunostaining in these puncta was
determined.
The GluR1-pS845 antibody was raised against a synthetic phos-
phopeptide corresponding to amino acids surrounding the Ser845 resi-
due of the rat GluR1 subunit and purified by sequential chromatography
on protein A and phospho- and dephospho-peptide affinity columns. On
Western blots of rat hippocampal homogenate, the antibody labels a
single band corresponding to a molecular weight of100 kDa (specifi-
cation of the manufacturer). Preabsorbtion controls for immunocyto-
chemistry were performed by adding the phosphopeptide used to raise
the antibody or the corresponding dephosphopeptide (0.1g/ml in each
case) to the antibody 24 hr before use.
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Results
GluR3 and GluR4 antibodies
The sequence used to generate the GluR3 antibody has a high
level of homology with the corresponding part of the GluR2 sub-
unit, and we therefore investigated whether this antibody cross-
reacted with GluR2. On dot blots, the GluR3 antibody detected
the R3C but not the R2C peptide, indicating that it did not cross-
react with the C-terminal portion of the GluR2 subunit. In West-
ern blots of the PSD fraction from mouse spinal cord, the GluR3
and GluR4 antibodies each detected a single protein band corre-
sponding to a molecular weight of 98 kDa. Staining with the
GluR3 antibody was blocked by preabsorption with R3C but not
R2C peptide, and the GluR4 staining was blocked with the R4N
peptide. On sections of pepsin-treated spinal cord, punctate staining
with GluR3 antibody was blocked by preabsorption with R3C but
not R2C peptide, whereas that with GluR4 antibody was blocked
with R4N peptide. Characterization data for these antibodies is
shown in supplemental Figure 1 (available at www.jneurosci.org).
General appearance of immunofluorescence with GluR1– 4
antibodies after antigen unmasking
On pepsin-treated spinal cord sections, punctate staining was
seen near the surface of the section (superficial 10 –15 m) with
each GluR antibody (Fig. 1). This became weaker deeper in the
section, and for the GluR2 antibodies was replaced by cell body
labeling identical to that reported without pepsin treatment
(Popratiloff et al., 1996, 1998). The loss of cytoplasmic labeling
suggests that extrasynaptic receptors are damaged during proteo-
lytic treatment, whereas synaptic receptors are presumably pro-
tected by the surrounding protein meshwork. The rabbit and
mouse GluR2 antibodies stained identical structures. Because
punctate staining was seen with antibodies directed against both
C-terminal (intracellular) (GluR1, GluR3, polyclonal GluR2)
and N-terminal (extracellular) (GluR4, monoclonal GluR2)
epitopes, proteolytic digestion presumably allows access to both
postsynaptic density and synaptic cleft. Lu et al. (2002) found that
after weak fixation, GluR2/3, GluR2/4, and GluR4 antibodies la-
beled central terminals of primary afferents in the dorsal horn. In
pepsin-treated tissue viewed with confocal microscopy, we did
not see a similar staining pattern with any of the GluR antibodies
used in this study, suggesting that epitopes on presynaptic recep-
tors are either damaged or remain inaccessible after pepsin
treatment.
Laminar distribution of AMPA subunits
Previous immunohistochemical and in situ hybridization studies
have suggested that GluR1 and GluR2 subunits are present
throughout the dorsal horn, with highest levels in laminas I and
II, that GluR2 is also present in the ventral horn, and that GluR3
and GluR4 are highly expressed in ventral horn, with moderate
levels in deep dorsal horn and limited expression in the superfi-
cial laminas (Furuyama et al., 1993; To¨lle et al., 1993; Tachibana
et al., 1994; Jakowec et al., 1995a,b; Harris et al., 1996; Popratiloff
et al., 1996, 1998; Morrison et al., 1998; Spike et al., 1998; En-
gelman et al., 1999; Shibata et al., 1999). Our findings after pepsin
treatment are consistent with these reports (Fig. 1). GluR1
Figure 1. Immunostaining for GluR1– 4 in the spinal cord after pepsin treatment. a–d show the medial part of the superficial dorsal horn (corresponding to laminas I–III). e–h include the medial
part of laminas IV and V. i–l are from lamina IX. GluR1-immunoreactive puncta are numerous in lamina II, present at lower density in other parts of the dorsal horn, and are virtually absent in lamina
IX. GluR2-immunoreactive puncta are present in all parts of the dorsal horn, but the labeling is strongest in lamina II. Punctate labeling with both GluR3 and GluR4 antibodies is seen throughout the
gray matter but is least dense in the superficial dorsal horn. Images of GluR1 and GluR2 are taken from one section, and those for GluR3 and GluR4 are taken from another. Each image was obtained
from a projection of three optical sections at 0.5m z-separation. Scale bar, 100m.
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showed the most restricted distribution,
with immunoreactive puncta being fre-
quent in lamina II, present at lower density
in other dorsal horn laminas but rarely
seen in the ventral horn. Numerous
GluR2-immunoreactive puncta were
present throughout the gray matter, with
the strongest labeling in laminas I–II.
GluR3- and GluR4-immunoreactive
puncta were densely distributed through-
out the ventral horn and laminas III-VI,
with much weaker labeling in laminas I
and II, although a few strongly labeled
puncta were seen in this region, particu-
larly in lamina I. It has been reported that
motoneurons express GluR1 (Pellegrini-
Giampietro et al., 1994; Virgo et al., 1996;
Temkin et al., 1997; Williams et al., 1997;
Bar-Peled et al., 1999; Shibata et al., 1999)
or lack GluR2 subunits (Williams et al.,
1997; Bar-Peled et al., 1999; Del Can˜o et
al., 1999; Shaw et al., 1999). Our results do
not support these suggestions, because we
found that in lamina IX, there was virtually
no punctate staining for GluR1, whereas
GluR2 was expressed at virtually all puncta
that contained any of the AMPA subunits
(see below).
In nonpepsin-treated sections, labeling
of cell bodies and small profiles that re-
sembled dendrites was seen with GluR1
and GluR2 antibodies. Numerous GluR2-
immunoreactive cell bodies were observed
throughout laminas I–III, whereas scat-
tered GluR1-labeled cell bodies were
present primarily in laminas I–II. However,
the immunofluorescent labeling with these
antibodies in sections that had not under-
gone pepsin treatment was much weaker
than that in pepsin-treated sections and
puncta of the type seen after pepsin treat-
ment were not visible (supplemental Fig. 2,
available at www.jneurosci.org). The GluR3
and GluR4 antibodies did not stain cell bod-
ies or give punctate labeling in the absence of
pepsin treatment. This suggests that conven-
tional immunocytochemistry without anti-
gen unmasking does not give significant la-
beling of synaptic AMPA receptors.
Colocalization of AMPA subunits
A specific question addressed in this part of the study was whether
any AMPA-containing glutamatergic synapses lacked GluR2
subunits and would therefore have exclusively Ca 2-permeable
AMPA receptors. We found that virtually all GluR1-
immunoreactive puncta throughout the dorsal horn were also
GluR2 immunoreactive (Fig. 2a–c), although the relative inten-
sity of labeling for the two subunits varied considerably between
puncta. The extent of colocalization of these two subunits was
investigated in the analysis of different types of glutamatergic
boutons (see below). Colocalization of GluR2, GluR3, and GluR4
was examined in triple-labeled sections (Fig. 2d– o; Table 1).
There was extensive colocalization of these subunits in all parts of
the gray matter ventral to lamina III, with most immunoreactive
puncta being triple labeled. The relationship was analyzed quan-
titatively in laminas I/II, III–V, and IX (Table 1). In laminas IV, V,
and IX, the great majority (90%) of labeled puncta were immu-
noreactive with all three antibodies. The proportions of puncta
that were triple labeled in lamina III and laminas I–II were 82 and
36%, respectively. Between 98 and 99% of the puncta that were
analyzed showed GluR2 immunoreactivity in all areas. The rela-
tive intensity of labeling for the three subunits varied between
puncta (Fig. 2d–o). Labeling of puncta with the GluR3 and GluR4
antibodies was generally much weaker in laminas I–II than in
other laminas, although a few puncta with strong GluR3 or
Figure 2. Colocalization of AMPA subunits. a–c show the same field from lamina II scanned to reveal GluR1 (red) and GluR2
(green). Note that all of the GluR1-immunoreactive puncta are also labeled with the GluR2 antibody, and that some GluR2-
immunoreactive puncta are not stained with the GluR1 antibody (3 of these are indicated with arrows). d–o show the relationship
between immunostaining for GluR2 (blue), GluR3 (green), and GluR4 (red) in lamina I (d–g), lamina IV (h–k), and lamina IX (l–o).
In each case, a merged image is shown in the right ( g, k, o). Nearly all of the labeled puncta in laminas IV and IX show all three types
of immunoreactivity. Although some colocalization of GluR2 with GluR3 and GluR4 immunoreactivity can be seen in d–g, some of
the puncta are only labeled with the GluR2 antibody (2 are indicated with arrows). All images show single optical sections. Scale
bar: a–o, 2m.
Table 1. Colocalization of GluR2, GluR3, and GluR4
Subunit combination
Lamina 2/3/4 2/3 2/4 3/4 2 3 4 GluR2 (%)
I/II 36 32.7 7.3 1 22.3 0.7 0 98.3
(31–39) (28 –35) (2–10) (0 –2) (22–23) (0 –1)
III 82 6.7 6.3 1.3 3.3 0.3 0 98.3
(77– 89) (4 –9) (4 –9) (0 –3) (1– 8) (0 –1)
IV 92 0.7 5 0 0.7 1.3 0.3 98.4
(91–93) (0 –1) (3–7) (0 –1) (1–3) (0 –1)
V 94.3 2 2 0.3 0.3 0.7 0.3 98.6
(92–96) (0 –3) (1–3) (0 –1) (0 –1) (0 –1) (0 –1)
IX 96 0 1.3 1.3 0.7 0.7 0 98
(95–98) (1–3) (0 –2) (0 –2) (0 –1)
Mean numbers of puncta showing different patterns of colocalization of immunostaining for GluR2, GluR3, and GluR4. One hundred immunoreactive puncta
were selected from each region in each of three rats. Ranges are given in parentheses.
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GluR4 immunoreactivity were seen here (Fig. 2d–g). In contrast,
the intensity of GluR2 immunoreactivity in individual puncta
was generally higher in laminas I and II than in other laminas.
Relationship of GluR1 and GluR2 to glutamatergic axons
Detection of VGLUT1, VGLUT2, and CGRP immunoreactivity
and IB4 binding with the TSA method before pepsin treatment
resulted in labeling patterns identical to those reported previ-
ously for these markers in the rat spinal cord (Sakamoto et al.,
1999; Varoqui et al., 2002; Todd et al., 2003). This shows that the
TSA reaction can be used to preserve immunostaining for labile
epitopes before antigen unmasking with pepsin. More than 90%
of the labeled boutons in each of these populations were in con-
tact with one or more GluR2-immunoreactive puncta (Figs. 3-5;
Table 2), and of the 4800 glutamatergic boutons analyzed in this
part of the study, 96.2% had at least one contact.
In all regions examined, each VGLUT1-immunoreactive bou-
ton was generally associated with more than one GluR2 punctum
(Table 2). In many cases, particularly in laminas IIi and III, clus-
ters of GluR2 puncta were seen surrounding VGLUT1-
immunoreactive boutons with an appearance that was consistent
with a glomerular arrangement (Fig. 3a–c). In laminas IIi and III,
the mean numbers of GluR2 puncta associated with each
VGLUT1 bouton were 4.2 and 3.7, respectively, whereas for lam-
ina IX, this figure was 5.5 (Fig. 3, Table 2). The mean numbers of
GluR2 puncta associated with VGLUT1 boutons in the other
laminas analyzed varied from 1.9 to 2.8 (Table 2). VGLUT2 bou-
tons were associated with significantly fewer GluR2 puncta (Fig.
4), with the mean number of puncta per bouton varying from 1.4
to 1.9 in different laminas (Table 2) (general linear model with
Tukey’s post hoc test; p 0.05 for lamina I; p 0.001 for all other
regions examined). For IB4-labeled axons in lamina II, the mean
number of GluR2 puncta per bouton was 4.8 (Fig. 5a–c), whereas
for CGRP-immunoreactive boutons in laminas I–IIo, the corre-
sponding value was 2.6 (Fig. 5d–f) (Table 3).
Many GluR1-immunoreactive puncta were observed in the
dorsal horn, and virtually all of these were also GluR2 immuno-
reactive (Figs. 3–5, Table 2). Only 18 (0.14%) of the 12,493
puncta identified on the 4800 boutons examined in this part of
the study showed GluR1 but not GluR2 immunoreactivity. Al-
though puncta that were both GluR1 and GluR2 immunoreactive
were associated with each type of axonal bouton in the dorsal
horn, this arrangement was not uniform. In laminas I and II,
between 30 and 40% of the GluR2 puncta associated with
VGLUT1 boutons was also GluR1 immunoreactive, whereas for
VGLUT2 boutons, the proportion was much lower, between 13
and 17% (Table 2). Similarly in laminas III and IV, 19% of puncta
adjacent to VGLUT1 boutons was GluR1 immunoreactive, com-
pared with 2– 4% for VGLUT2 boutons (Table 2). The propor-
tion of puncta showing both GluR1 and GluR2 immunoreactivity
was significantly higher for VGLUT1 than for VGLUT2 boutons
in each of laminas I–IV (general linear model with Tukey’s post
hoc test; p 0.05 for laminas I and III; p 0.01 for laminas IIo,
Iii, and IV). For the IB4 and CGRP boutons, the proportions of
GluR2 puncta that were also GluR1 immunoreactive were 34 and
31%, respectively (Table 3), and these values were significantly
different from those for VGLUT2 boutons in the corresponding
laminas (general linear model with Tukey’s post hoc test; p 
0.05). These results suggest that GluR1-containing synapses are
preferentially associated with primary afferent terminals.
To determine whether a significant proportion of the GluR2-
immunoreactive puncta seen after pepsin treatment represented
nonsynaptic (e.g., cytoplasmic) receptors, we analyzed sections
reacted with GluR2, VGLUT1, and VGLUT2 antibodies. Between
49 and 60% (mean, 55.7) of GluR2 puncta in laminas I–II were
associated with a bouton that was VGLUT1 or VGLUT2 immu-
noreactive. The corresponding values for laminas III–IV were
84 – 89% (mean, 86.3), and for lamina IX they were 83– 87%
(mean, 84.7). This suggests that for the deep dorsal horn and
ventral horn, at least 85% of puncta are associated with glutama-
tergic synapses, and because VGLUT1 and VGLUT2 antibodies
do not stain all glutamatergic axons, this figure is probably an
underestimate. Because boutons belonging to C fibers are often
not labeled with VGLUT1 or VGLUT2 antibodies (Todd et al.,
2003), these are likely to account for many of the GluR2 puncta
that were not in contact with a VGLUT1- or VGLUT2-containing
bouton in laminas I and II (Fig. 5).
Electron microscopy
Although the ultrastructure was compromised by pepsin treat-
ment, it was frequently possible to identify immunoreactive syn-
apses with both GluR1 and GluR2 antibodies, and in all cases,
Figure 3. GluR1 and GluR2 puncta associated with VGLUT1-immunoreactive boutons. In
each case, GluR2 immunostaining is shown in green in the left panel, GluR1 in blue in the center
panel, and these have been merged with VGLUT1 staining (red) in the right panel. a–c are from
lamina IIi. d–f are from lamina IV. g–i are from lamina IX. In all cases, the VGLUT1 boutons
contact GluR2-immunoreactive puncta. In the dorsal horn, some of these puncta are also GluR1
immunoreactive. In lamina IIi, these puncta often surround the VGLUT1 bouton, with an ap-
pearance that is suggestive of a glomerular arrangement (arrows). Note that occasional overlap
between GluR-immunoreactive puncta and axonal staining is likely to be attributable to either
invagination of a dendrite into a bouton or obliquity of the synapse with respect to the plane of
section. All images were obtained from single optical sections. Scale bar, 2m.
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reaction product was restricted to the postsynaptic profile and
associated with the postsynaptic density (Fig. 6). This is consis-
tent with a cytoplasmic location for the C terminal of these sub-
units and confirms that puncta seen adjacent to glutamatergic
boutons with confocal microscopy correspond to postsynaptic
receptors.
With both antibodies, reaction product was occasionally seen
in cell bodies, nonsynaptic regions of dendrites, and vesicle-
containing profiles. While scanning an area that contained 50
immunoreactive synapses on each section, we found three im-
munoreactive vesicle-containing profiles in each of the two
GluR1 sections analyzed and one in one of the GluR2 sections.
One of these profiles (that was found in the GluR2 section) was
presynaptic at an asymmetrical synapse and was therefore pre-
sumably an axonal bouton. The reaction product in this profile
was not associated with the presynaptic membrane but was lo-
cated in the center of the bouton. The other six vesicle-containing
profiles did not form synapses in these sections, and it was not
possible to determine whether these were axons or vesicle-
containing dendrites. In formaldehyde-fixed tissue treated with
pepsin and viewed with confocal microscopy, we never saw
GluR1-immunoreactive cell bodies, and GluR2-immunoreactive
cell bodies were only seen in deeper parts of the section. The
finding of occasional GluR1- and GluR2-immunoreactive cell
bodies near the surface of pepsin-treated sections processed for
electron microscopy suggests that glutaraldehyde can protect
nonsynaptic AMPA receptor subunits from loss during pepsin
digestion. If glutaraldehyde also preserves some presynaptic re-
ceptors during pepsin treatment, this may account for some of
the labeled vesicle-containing profiles seen with EM.
Numerous synapses were seen in the sections that had been
reacted with GluR1 and GluR2 antibodies without pepsin treat-
ment; however, none of these was immunoreactive with either
antibody. This is consistent with our failure to see punctate stain-
ing for GluR1 and GluR2 with confocal microscopy on sections
that had not been pepsin treated.
Our findings with confocal and electron microscopy, taken
together with studies that have revealed presynaptic receptors on
lightly fixed material (Lu et al., 2002), suggest that receptor sub-
units at different subcellular locations are affected differently by
fixation and pepsin treatment. It is likely that no single method
can provide simultaneous labeling of receptor subunits in all
locations.
Detection of GluR1-pS845 after capsaicin injection
Strong punctate immunostaining corresponding to GluR1-
pS845 was observed in sections from the rats that received injec-
tions of capsaicin 10 min before fixation. This was primarily re-
stricted to the medial half of laminas I–II on the ipsilateral side
(Figs. 7, 8a–f), although a few moderately immunoreactive
puncta were seen on the contralateral side. The distribution of
strongly labeled puncta in the medial part of the ipsilateral super-
ficial dorsal horn matches that of nociceptive afferents that innervate
the plantar surface of the foot. The GluR1-pS845-immunoreactive
puncta were almost invariably also labeled with the GluR2 anti-
body (Fig. 8a–c; Table 4) but were greatly outnumbered by
GluR2immunoreactive puncta that lacked GluR1-pS845 immuno-
reactivity. Between 67 and 126 puncta with pixels exceeding the
threshold luminance value were seen ipsilaterally in medial laminas
I–II in a single optical section (1.66–3.3/1000m2) compared with
between 4 and 14 puncta (0.1–0.37/1000m2) in the corresponding
part of the contralateral dorsal horn (Table 4). This difference was
significant (Mann–Whitney, one-tailed U test; p  0.05). Staining
Figure 4. GluR1 and GluR2 puncta associated with VGLUT2-immunoreactive boutons. In
each case, GluR2 immunostaining is shown in green in the left panel, GluR1 in blue in the center
panel, and these have been merged with VGLUT2 staining (red) in the right panel. a–c are from
lamina I. d–f are from lamina V. g–i are from lamina IX. Note that VGLUT2 boutons are associ-
ated with few GluR2-immunoreactive puncta and that some of the puncta in contact with these
boutons in the dorsal horn are also GluR1 immunoreactive. All images were obtained from
single optical sections. Scale bar, 2m.
Figure 5. GluR1 and GluR2 puncta associated with terminals of fine afferents in lamina II.
a–c show GluR2 (green) and GluR1 (blue) immunoreactivity, together with binding of IB4 (red).
The IB4-labeled boutons are in contact with GluR2-immunoreactive puncta, some of which are
also GluR1 immunoreactive. In many cases, the IB4 boutons were surrounded by immunoreac-
tive puncta with an appearance that was suggestive of a glomerular arrangement (arrow). d–f,
GluR2 (green), GluR1 (blue), and CGRP (red) immunoreactivity. The CGRP boutons are associ-
ated with GluR2-immunoreactive puncta, some of which are also GluR1 immunoreactive. All
images were obtained from single optical sections. Scale bar, 2m.
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was abolished by preabsorbing the antibody with the phosphopep-
tide but not the dephosphopeptide (Fig. 8g–i), indicating that it is
specific for GluR1-pS845.
In addition to the strongly labeled puncta, numerous very
weakly immunoreactive puncta were seen
throughout the superficial dorsal horn on
both sides with the GluR1-pS845 anti-
body, and again these were generally also
GluR2 immunoreactive. This weak stain-
ing is likely to reflect a low basal level of
phosphorylation of GluR1 subunits at glu-
tamatergic synapses, whereas the substan-
tial increase in staining in the medial part
of the superficial dorsal horn ipsilaterally
presumably results from increased phos-
phorylation of GluR1 at S845 in response
to capsaicin injection (Fang et al., 2003).
Discussion
The main finding of this study was that
antigen unmasking with pepsin revealed
punctate labeling for all four AMPA re-
ceptor subunits in the spinal cord. These
puncta represent synaptic receptors, as
judged by their relationship with glutama-
tergic boutons and the results of electron
microscopy. There was extensive colocal-
ization between the subunits, with GluR2
being present at nearly all immunoreac-
tive puncta throughout the gray matter,
which suggests that GluR2 is almost universally expressed at
AMPA-containing synapses throughout the spinal cord. In addi-
tion, we showed that noxious stimulation leads to phosphoryla-
tion of synaptic GluR1 subunits at the S845 residue.
Figure 6. Electron microscopic appearance of GluR1 and GluR2 in the superficial dorsal horn after pepsin treatment. a–c show
GluR1 immunolabeling. d–f show GluR2 immunolabeling. Immunoperoxidase reaction product is associated with the postsyn-
aptic aspect of synapses (arrows). Scale bar, 0.5m.
Table 2. Association of GluR1 and GluR2 puncta with VGLUT-immunoreactive boutons
Lamina
VGLUT1 VGLUT2
Percentage of
boutons with1
GluR2 puncta
Percentage of
boutons with1
GluR1 puncta
Mean GluR2
puncta per
bouton
Percentage of
GluR2 puncta
with GluR1
Percentage of
boutons with1
GluR2 puncta
Percentage of
boutons with1
GluR1 puncta
Mean GluR2
puncta per
bouton
Percentage of
GluR2 puncta
with GluR1
I 91.7 40.3 1.9 29.8** 92 16.7 1.4 12.9
(89 –94) (34 – 44) (1.6 –2.3) (23.1–35.0) (88 –100) (9 –24) (1.1–1.7) (8.2–17.2)
IIo 95.0 64.3 2.8 40.2 97.3 24.7 1.6 17.0*
(91–99) (53–71) (2.6 –3.4) (30.7–55.0) (96 –100) (19 –28) (1.4 –1.8) (15.4 –19.6)
IIi 98.3 76.3 4.2 38.1** 96.7 24 1.6 16.9
(97–100) (73– 82) (3.4 – 4.7) (32.7– 41.0) (92–100) (16 –29) (1.4 –1.7) (11.6 –20.6)
III 96.0 44.3 3.7 19.0*** 95 5 1.4 3.6
(95–97) (30 – 60) (3.0 – 4.2) (15.5–24.0) (90 –100) (4 –7) (1.3–1.5) (2.7– 4.9)
IV 93 31.7 2.6 19.4** 96.7 4.3 1.6 1.9***
(89 –95) (29 –33) (2.2–3.2) (14.7–24.9) (96 –98) (0 –11) (1.4 –1.9) (0 – 4.3)
V 94 21 2.6 10.4** 97.7 1.7 1.5 0.8*
(91–99) (16 –26) (2.4 –2.9) (7.3–14.0) (95–100) (0 – 4) (1.2–1.7) (0 –1.9)
IX 97.3 4.3 5.5 0.8** 97.7 0 1.9 0
(97–98) (0 –11) (3.9 – 6.4) (0 –1.8) (97–99) (1.6 –2.2)
The proportion of VGLUT1- and VGLUT2-immunoreactive boutons that were adjacent to GluR1 and GluR2 puncta, together with the mean number of GluR2 puncta that contacted each bouton in each group, and the percentage of these that
were also GluR1 immunoreactive are shown. One hundred boutons with each type of VGLUT immunoreactivity were examined in each region in three rats. Ranges are given in parentheses. Very few puncta were GluR1 but not GluR2
immunoreactive. The number of these in the sample of 300 VGLUT-immunoreactive boutons in each group is indicated by asterisks as follows: *one; **two; ***three.
Table 3. Association of GluR1 and GluR2 puncta with CGRP- and IR4-labeled boutons
Lamina
CGRP IB4
Percentage of
boutons with1
GluR2 puncta
Percentage of
boutons with1
GluR1 puncta
Mean GluR2
puncta per
bouton
Percentage of
GluR2 puncta
with GluR1
Percentage of
boutons with1
GluR2 puncta
Percentage of
boutons with1
GluR1 puncta
Mean GluR2
puncta per
bouton
Percentage of
GluR2 puncta
with GluR1
I 93.3 50.3 2.6 34.4
IIo (92–94) (38 –58) (2.4 –2.9) (27.0 – 42.3) 100 77.3 4.8 30.7
IIi (69 –93) (4.5–5.2) (24.9 –35.4)
The proportion of CGRP-immunoreactive and IB4-labeled boutons that were adjacent to GluR1 and GluR2 puncta, together with the mean number of GluR2 puncta that contacted each bouton in each group, and the percentage of these that
were also GluR1 immunoreactive are shown. One hundred boutons of each type were examined from laminae I–IIo (CGRP) or lamina II (IB4) in three rats. Ranges are given in parentheses. In these populations, all GluR1-immunoreactive
puncta were also GluR2 positive.
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Laminar distribution of AMPA subunits and relationship to
glutamatergic axons
Although studies with in situ hybridization and conventional im-
munocytochemistry have provided information about the lami-
nar distribution of neurons with different subunits, they do not
allow us to determine the proportions of neurons that express a
particular subunit or the extent of colocalization of subunits
within neurons or at individual synapses. Based on the assump-
tion that all spinal neurons possess AMPA receptors, our results
suggest that at midlumbar levels, all (or virtually all) dorsal horn
neurons and motoneurons express the GluR2 subunit, that
GluR1 is restricted to certain dorsal horn cells (particularly those
in the superficial laminas) and is not expressed by motoneurons,
and that GluR3 and GluR4 are expressed by all (or virtually all)
motoneurons, by the great majority of neurons in the deep dorsal
horn (laminas III–V), and by some of those in the superficial
laminas. The extensive colocalization of GluR2, GluR3, and
GluR4 at puncta in laminas IV, V, and IX suggests that neurons in
these laminas have all three subunits at the great majority of
synapses that possess AMPA receptors.
Because our findings suggest that the GluR2 subunit is almost
universally present at AMPA-containing synapses in midlumbar
spinal cord, we examined the relationship of GluR2 to several
types of glutamatergic axon. Most VGLUT1-immunoreactive
boutons from lamina IIi–IX are central terminals of myelinated
primary afferents, whereas the majority of VGLUT2-containing
axons are probably derived from excitatory interneurons (Todd
et al., 2003). We found that VGLUT1 boutons were adjacent to
significantly more puncta than those with VGLUT2 in all laminas
examined. Puncta seen with confocal microscopy do not neces-
sarily represent individual synapses but could correspond to ac-
tive sites within a synapse. Many VGLUT1-immunoreactive pro-
files in lamina IX are terminals of Ia muscle-spindle afferents
(Todd et al., 2003). Pierce and Mendell (1993) reported that most
Ia afferent boutons in the cat were presynaptic to a single element,
but that the mean number of active sites at these synapses was 6.1.
The mean number of GluR2 puncta that we found on VGLUT1
boutons in lamina IX was 5.5, and these puncta therefore pre-
sumably correspond to active sites within individual synapses.
VGLUT1-immunoreactive boutons in laminas IIi and III proba-
bly include A down-hair afferents, which form central axons of
type II synaptic glomeruli (Re´thelyi et al., 1982; Ribeiro-da-Silva
and Coimbra, 1982), and we often observed clusters of GluR2
puncta surrounding VGLUT1 axons in this region. A afferents
terminate widely in laminas III–V and form simpler synaptic
arrangements on a few different postsynaptic elements (Maxwell
and Re´thelyi, 1987). Consistent with this, the number of puncta
associated with VGLUT1 boutons was lower in laminas IV and V.
Less is known about synaptic connections formed by axons of
excitatory interneurons, but the number of puncta associated
with VGLUT2-immunoreactive boutons (1.4 –1.9) suggests that
these have simpler arrangements, in many cases with only a single
postsynaptic element. Many of the IB4-labeled terminals corre-
spond to type I synaptic glomeruli (Ribeiro-da-Silva and Coim-
bra, 1982), and these were also frequently surrounded by clusters
of GluR2 puncta (Fig. 5).
Interestingly, the proportions of GluR2 puncta that were also
GluR1 immunoreactive were significantly higher for VGLUT1
boutons than for VGLUT2 boutons in laminas I–IV, and in the
superficial laminas IB4- and CGRP-labeled boutons were also
associated with more GluR1 puncta than were VGLUT2 boutons.
This suggests that GluR1 is more often present at synapses
formed by primary afferents than at those formed by excitatory
interneurons. There are two possible explanations for this: either
neurons that express GluR1 receive relatively more primary af-
ferent synapses than other neurons, or alternatively GluR1 is se-
lectively targeted to synapses formed by primary afferents. Selec-
tive targeting of AMPA subunits has been reported previously in
the CNS (Rubio and Wenthold, 1997). The presence of GluR1 at
synapses formed by nociceptive afferents is important because
GluR1 (and GluR4-)-containing receptors are inserted into glu-
tamatergic synapses in response to synaptic activity, unlike those
that contain only GluR2 or GluR3, which are constitutively in-
serted (Bredt and Nicoll, 2003). This suggests that insertion of
new receptor subunits could contribute to activity-dependent
plasticity at synapses formed by these afferents.
Baba et al. (2000) reported that silent synapses (those with
NMDA but not AMPA receptors) were extremely rare in laminas
II–III of the adult rat spinal cord. Although we cannot determine
the proportion of glutamatergic synapses at which AMPA recep-
tors were present, our finding that fewer than 5% of 3000 gluta-
matergic boutons analyzed in laminas I–III lacked GluR2 puncta
is consistent with this observation.
Ca 2-permeable AMPA receptors
One of the major interests in AMPA receptors in the spinal cord
has been the presence of Ca 2-permeable receptors. These have
been identified on both dorsal horn neurons (Engelman et al.,
1999; Stanfa et al., 2000) and motoneurons (Vandenberghe et al.,
2001; van Damme et al., 2002). Ca 2-permeable AMPA recep-
tors in the dorsal horn are thought to be responsible for tactile
allodynia after a noxious thermal stimulus or carrageenan-
induced inflammation (Sorkin et al., 1999, 2001). Those on mo-
toneurons appear to be involved in the excitotoxicity that is
thought to underlie amyotrophic lateral sclerosis. Ca 2 perme-
ability is prevented by the presence of GluR2 subunits in which
Figure 7. Immunostaining for GluR1-pS845 in a section from L4 in a rat that received an
intraplantar capsaicin injection. a shows the medial part of the superficial dorsal horn on the left
side (ipsilateral to the injection), and b shows the corresponding part of the right dorsal horn.
The dotted line indicates the border between gray and white matter. Numerous immunoreac-
tive puncta are visible in the superficial laminas on the ipsilateral side, but these are rarely seen
on the contralateral side. Each image was obtained from a projection of 11 optical sections at 0.5
m z-separation. Scale bar, 100m.
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arginine at position 586 has been changed to glutamine by means
of RNA editing. Because GluR2 subunits in the adult rat spinal
cord are mostly in the edited form (Vandenberghe et al., 2000), it
is likely that Ca 2-permeable AMPA receptors lack the GluR2
subunit. Our results suggest that all spinal neurons express GluR2,
and therefore neurons that possess Ca2-permeable AMPA recep-
tors presumably also synthesize receptors that contain GluR2 and
are Ca2 impermeable (Vandenberghe et al., 2001; van Damme et
al., 2002). Because AMPA receptor subunits may be selectively di-
rected to particular postsynaptic targets on a neuron (Rubio and
Wenthold, 1997), it is possible that some synapses might lack GluR2
and therefore have exclusively Ca2-
permeable receptors. Evidence for this has
been provided by Vandenberghe et al.
(2000), who reported that 8% of the clusters
of GluR4 immunoreactivity on cell bodies
and dendrites of cultured motoneurons
were not GluR2 immunoreactive. However,
our results suggest that in vivo, very few
(2%) active sites with AMPA receptors
lack GluR2, even though the relative concen-
trations of the different subunits can vary
considerably. It is therefore likely that for
neurons with Ca2-permeable AMPA re-
ceptors, these are intermingled with GluR2-
containing receptors within the same active
sites.
Phosphorylation of GluR1 subunits
Phosphorylation of AMPA receptors is
known to play an important role in both
long-term potentiation (LTP) and depres-
sion (Song and Huganir, 2002; Bredt and
Nicoll, 2003). The GluR1 subunit has two
major phosphorylation sites, S831 and
S845 (Roche et al., 1996), and mice in
which these residues are mutated to pre-
vent phosphorylation show reduced hip-
pocampal LTP and loss of memory reten-
tion (Lee et al., 2003). Phosphorylation of
GluR1 at the S845 site by protein kinase A
results in a 40% enhancement of peak cur-
rent flow through homomeric GluR1
channels in transfected cells (Roche et al.,
1996) because of an increase in peak open-
channel probability (Banke et al., 2000). In
addition, phosphorylation of the S845 site
is necessary for the incorporation of addi-
tional GluR1 subunits into glutamatergic
synapses that is thought to contribute to
synaptic plasticity (Esteban et al., 2003).
AMPA receptor phosphorylation has
also been implicated in the central sensiti-
zation of dorsal horn neurons that con-
tributes to chronic pain states (Sandku¨-
hler, 2000; Fang et al., 2003; Ji et al., 2003).
Our results suggest that there is normally a
very low level of phosphorylation of GluR1
at the S845 site in glutamatergic synapses
in the dorsal horn, but that this can be sub-
stantially increased in a subset of synapses
in a somatotopically appropriate location
within 10 min of capsaicin injection, a
stimulus that is known to cause central sensitization (Simone et
al., 1991). Interestingly, Chung et al. (2000) reported that al-
though there were relatively high levels of phosphorylated GluR2
(at S880) in dendritic shafts of cultured hippocampal neurons,
the level of phosphorylation at synapses was very low, and that
activation of protein kinase C resulted in phosphorylation of syn-
aptic receptors.
Our study apparently provides the first demonstration of
phosphorylation of iGluRs at synapses in vivo. It reveals that nox-
ious stimulation induces rapid phosphorylation of GluR1 sub-
units at glutamatergic synapses and provides a novel approach for
Table 4. pSer845 GluR1 immunoreactivity after injection of capsaicin
Left Right
Rat
pSer845 GluR1
puncta
pSer845 GluR1
puncta per 1000M2
Percentage
with GluR2
pSer845 GluR1
puncta
pSer845 GluR1
puncta per 1000M2
Percentage
with GluR2
1 96 2.412 99 14 0.372 100
2 126 3.295 100 4 0.097 50
3 67 1.657 96 9 0.232 56
The number of pSer845 GluR1-immunoreactive puncta in the medial half of each dorsal horn in a single optical section from three rats that received injections
of 250g of capsaicin into the plantar surface of the hindpaw 10 min before perfusion fixation. The table shows the total number of puncta containing at least
one pixel that exceeded the threshold luminance value (see Materials and Methods), the number of puncta per 1000M2, and the proportion of these puncta
that were also GluR2 immunoreactive. The density of pSer845 GluR1-immunoreactive puncta was significantly higher on the ipsilateral side than on the
contralateral side (p 0.05; Mann–Whitney one-tailed U test).
Figure 8. High-magnification views of GluR1-pS845 staining and absorption controls. a–c show part of laminas I and II on the
side ipsilateral to the capsaicin injection (from the section illustrated in Fig. 7). Several puncta that are strongly labeled with the
GluR1-pS845 antibody (red) are visible (2 indicated with arrows). All of these are also GluR2 immunoreactive (green) and appear
yellow in the merged image. d–f, A similar region from the superficial dorsal horn on the contralateral side of the same section.
GluR1-pS845 staining is much fainter. g–i show corresponding parts of the superficial dorsal horn ipsilateral to the capsaicin
injection in sections reacted with GluR1-pS845 antibody. The section in h was preincubated in dephosphopeptide (dp), that in i in
phosphopeptide (pp), whereas that in g did not have any peptide added. Each of these sections is from the same animal and was
scanned under identical conditions. The punctate immunostaining is abolished by the phosphopeptide but is not affected by the
dephosphopeptide. All images are from single optical sections. Scale bar, 20m.
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investigating central sensitization and other forms of synaptic
plasticity in specific neuronal circuits throughout the CNS.
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